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Intensive care unit- (ICU-) acquired infections are a major health problem worldwide. Inanimate surfaces and equipment
contamination may play a role in cross-transmission of pathogens and subsequent patient colonization or infection. Bacteria
contaminate inanimate surfaces and equipment of the patient zone and healthcare area, generating a reservoir of potential
pathogens, including multidrug resistant species. Traditional terminal cleaning methods have limitations. Indeed patients who
receive a bed from prior patient carrying bacteria are exposed to an increased risk (odds ratio 2.13, 95% confidence intervals
1.62–2.81) of being colonized and potentially infected by the same bacterial species of the previous patient. Biofilm formation,
even on dry surfaces, may play a role in reducing the efficacy of terminal cleaning procedures since it enables bacteria to survive
in the environment for a long period and provides increased resistance to commonly used disinfectants. No-touch methods (e.g.,
UV-light, hydrogen peroxide vapour) are under investigation and further studies with patient-centred outcomes are needed, before
considering them the standard of terminal cleaning in ICUs. Healthcare workers should be aware of the role of environmental
contamination in the ICU and consider it in the broader perspective of infection control measures and stewardship initiatives.
1. Introduction
Intensive care unit- (ICU-) acquired infections are a major
health problemworldwide. Emergence of multidrug resistant
organisms (MDROs) poses a daily challenge to ICU physi-
cians, dealing with critically ill patients with multiple risk
factors for infections (i.e., impairment of body barriers due to
invasive devices and surgery, immunosuppression, prolonged
antibiotic exposure) [1–4]. A relevant body of evidence
highlights the high prevalence of contamination of high-
touch surfaces and equipment surrounding patients’ bed
[5]. Indeed, the patient’s nearby environment is crowded by
equipment for monitoring and organ support (e.g., monitors,
ventilator, extracorporeal life support machines), requiring
sophisticated and specific cleaning procedures. Contamina-
tion of inanimate surfaces may occur as the consequence
of direct patient shedding of bacteria (higher from infected
than colonized patients) or via healthcare workers’ (HCWs’)
hands. HCWs contaminate their hands from inanimate
surfaces as frequently as direct patient contact [6]. In a
randomized cross-over study, recontamination of high-touch
surfaces in ICU occurred after only 4 hours from standard
cleaning measures [7]. Environmental contamination in the
ICU involves not only equipment for direct patient care (e.g.,
stethoscopes, ultrasound equipment, surfaces of mechanical
ventilators) but also surfaces of objects used for clinical
data recordings (i.e., medical charts, computer keyboard, and
mouse) and mobile phones [8]. Environmental contamina-
tion has been identified as a major contributor of bacteria
cross-transmission and patient colonization and infection. In
1991, Weinstein [9] estimated the relative contribution of dif-
ferent potential sources for ICU-acquired infections: 40–60%
patient’s endogenous flora, followed by cross-infection via
HCWs’ hands (20–40%), antibiotic-driven changes in flora
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Figure 1: Patient zone with more frequently isolated bacteria contaminating inanimate surfaces and equipment.
(20–25%), and other sources (including environmental con-
tamination, 20%). Understanding the mechanisms under-
lying cross-transmission of pathogens from inanimate sur-
faces and equipment may contribute to lay the foundation
of effective infection control measures aiming to halt the
spread of healthcare-associated infections. The aim of this
review is to provide updated evidence on environmental
contamination in the ICU, focusing onmechanisms by which
bacteria are able to survive on inanimate surfaces, describing
the concept of patient zone and healthcare area and the role of
contamination for ICU-acquired colonization and infection.
1.1. The Concepts of Patient Zone and Healthcare Area. The
concepts of patient zone and healthcare area have been
introduced as a user-centred, operative behaviour aiming
to enhance hand hygiene compliance [10]. The patient zone
encompasses the patient and surfaces and equipment sur-
rounding him/her (i.e., bed rails, ventilator, monitors). The
healthcare area is composed of all surfaces outside a given
patient zone (i.e., the healthcare facility environment and
other patient zones) [8].
The healthcare area may be contaminated by bacteria
fromdifferent patient zones. Inanimate surfaces in the patient
zone are contaminated by bacteria colonizing/infecting
patients in two ways: direct shedding from patients and via
HCWs’ hands. High-touch objects in the immediate vicinity
of patients are heavily contaminated. A higher degree and
rate of contamination occur from infected patients than from
patients who are only colonized. Moreover, a correlation
exists between number of culture-positive body sites and
environmental contamination [11, 12]. A high degree of
patient zone contamination has been reported also in case of
patients with diarrhea [13, 14].
Figure 1 shows a patient zone with most frequently
reported contaminating bacteria in the literature.
1.2. ICU-Acquired Colonization and Infection: Update on
Available Evidence. Evidence on the role of environmental
contamination for cross-transmission of pathogens comes
from studies reporting on outbreaks of infections driven by
contaminated objects or equipment, studies investigating the
association of colonized/infected patients with environmen-
tal and HCWs’ hands contamination, and studies reporting
on the risk of acquiring bacteria from prior bed occupants
[15]. Hand-washing sinks, bottled still water, and broncho-
scope suction valves have been related to outbreaks registered
in ICUs, with the same strains and antibiotic susceptibility
profiles registered in those isolated from colonized/infected
patients [16–21]. This observation is of value when we
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consider the role of inanimate surfaces contamination as a
reservoir of MDROs of potentially pathogen role.
In their cohort study, Morgan et al. [22] investigated
how frequently HCWs contaminated gloves and gowns after
contact with patients. Approximately, after one of every three
interactions with a patient carryingAcinetobacter baumannii,
HCWs contaminated their gloves and gowns. A. bauman-
nii was present in almost 80% of rooms from colonized
patients. Contamination with A. baumannii occurred more
frequently than with other bacteria (Pseudomonas aerug-
inosa, vancomycin-resistant Enterococci and methicillin-
resistant Staphylococcus aureus). Independent risk factors for
HCWs contamination byMDROswere positive environmen-
tal cultures (OR 4.2, 95% CI 2.7–6.5), stay in room for more
than 5minutes (OR 2.0, 95%CI 1.2–3.4), performing physical
examination (OR 1.7, 95% CI 1.1–2.8), and contact with the
ventilator (OR 1.8, 95% CI 1.1–2.8) [22].
A number of studies reported on a higher risk of acquir-
ing bacteria from prior room occupants. This independent
risk factor occurred for both Gram-positive (S. aureus,
Enterococcus species, Clostridium difficile) andGram-negative
bacteria (Acinetobacter spp., P. aeruginosa, Klebsiella pneu-
moniae) [23], including MDROs (MRSA, VRE). We recently
performed a meta-analysis of studies investigating this issue
in the ICU setting [24]. The pooled OR of acquisition
of bacteria from prior bed occupants was 2.13 (95% CI
1.62–2.81). When we considered the OR for the acquisition
according to bacterial species, we registered the highest
OR for A. baumannii (OR 4.91, 95% CI 2.79–8.64) and C.
difficile (OR 2.57, 95% CI 1.28–5.15). It is remarkable that this
increased risk occurs even when current terminal cleaning
procedures are addressed. We may speculate that these
findings may be explained by suboptimal terminal cleaning
procedures resulting in persisting surfaces contamination.
Environmental contamination may represent the reservoir
for cross-transmission of bacteria via HCWs’ hands. Struc-
tural ICU features may be associated with a different degree
of environmental contamination and cross-transmission rate.
Indeed, single-room ICUs have the theoretical advantage of
a physical separation of different patient zones. This may
be also associated with the ease of adoption of enhanced
terminal cleaning procedures requiring environment isola-
tion. However, cross-transmission of bacteria from prior bed
occupant occurred in single-room ICUs in most studies [25].
1.3. Terminal Cleaning in ICU. The term terminal cleaning
refers to all methods used for disinfection of either a room or
a patient zone between occupying patients (i.e., after patient
discharge). Quaternary ammonium and bleach are the most
commonly used products for this purpose.The efficacy of ter-
minal cleaning relies on different factors, including training
and management of personnel (e.g., adequate contact time,
compliance with protocols) and accessibility of surfaces. If
we consider the higher patient’s risk of acquiring a MDRO
if exposed to the bed of a previously colonized/infected
patient, current terminal cleaningmethods are far frombeing
considered a highly effective procedure. Inadequate cleaning
as assessed by objective measures of operators’ performance
has been reported in different studies. Programs including
a training phase, followed by an objective monitoring of
operators’ performance through the use of assays such as
adenosine triphosphate (ATP) bioluminescence, resulted in
an overall improvement of performance and reduced degree
of environmental contamination [26, 27]. In a prospective
study [28], authors investigated a bundle of interventions
aiming to enhance room cleaning in ICUs after patient
discharge. They collected baseline cleaning performance
using a mark visible only with an ultraviolet lamp (black-
light indicator). Study interventions consisted of an increased
disinfectant volume application, an educational campaign
involving the cleaning staff and the adoption of a black-light
monitoring system for feedback. The indicator was removed
from 72% of surfaces after the interventions, compared to
44% cleaned surfaces at baseline (𝑝 < 0.001). The interven-
tions also reduced the environmental positive cultures for
MRSAandVRE [28]. Similar results were reported in another
prospective study conducted in 27 ICUs where only 49.5% of
selected surfaces were cleaned at baseline, compared to 82%
after a structured educational, procedural, administrative
intervention and objective feedback provided by a fluorescent
marker [29].
In 2010 the Centres for Disease Control and Preven-
tion provided a toolkit with a bundle of interventions for
improvement of hospital cleaning. Objective assessment has
been incorporated among the interventions to apply to
enhance cleaning performance. The proposed methods were
direct cleaning practice observation, swab and agar slide
cultures, fluorescentmarkers, andATPbioluminescence [30].
Recently, no-touch terminal cleaning procedures have been
investigated in ICUs.They consist of the use of either physical
(e.g., ultraviolet, UV-light) or chemical agents (e.g., hydrogen
peroxide, H
2
O
2
vapour, HPV) delivered by specific devices
without the active role of personnel. The theoretical advan-
tages of these techniques are a higher overall performance
given the capability to disinfect difficult to reach surfaces,
difficult to clean equipment, and the lack of reliance on
personnel performance.
UV-light generates DNA and RNA alterations leading to
an irreversible damage and killing of microorganisms. The
device is normally placed in the roomcentre and it is activated
by remote control. Surfaces receiving direct irradiation are
exposed to the highest killing potential but wall, floor, and
other surfaces are able to reflect the UV-light and indirectly
expose other surfaces. However, shadowed areas may not
receive a sufficient radiation dose and UV-light does not
penetrate porous surfaces. Two different UV-power levels
are available for killing of vegetative and spore-forming
pathogens. Different studies reported the high capacity of
UV radiation to significantly reduce the contamination of
high-touch surfaces by a number of pathogens (MRSA, VRE
and C. difficile) [31, 32]. Compared to HPV, UV-light decon-
tamination is cheaper to operate and maintain and requires
less time [33]. Anderson et al. [34] recently performed a
large (31226 exposed patients) multicentre randomized study
investigating the adoption of enhanced terminal cleaning
procedures of seed rooms by previously colonized/infected
patients. They compared 4 different strategies: UV-light
combined with quaternary ammonium, UV-light combined
4 BioMed Research International
with bleach, bleach, and reference (quaternary ammonium).
Notably, according to their standard cleaning protocol, bleach
was used as reference for rooms seed by C. difficile. Adding
UV-light led to a reduction of the incidence of colonization
and infection caused by MRSA and VRE, while authors did
not observe a statistically significant difference when UV-
light was compared to bleach. Of note, only one outcome
occurred forAcinetobacter and therefore the role of enhanced
terminal cleaning was not investigated for this pathogen.The
lack of benefit forC. difficile cross-transmissionwas explained
by the adoption of an enhanced procedure also in the refer-
ence group (i.e., bleach), the high compliance of personnel
to the cleaning protocol (which may be significantly lower in
real life), and the use of a single-stage cycle of UV-light for a
pathogen with a time- and dose-dependent response to UV-
light. Despite these limitations, this is the first trial to date
enrolling such a high number of patients and adopting the
clinically relevant outcomes of infections and colonization
[35].
H
2
O
2
is a noncorrosive agent showing bactericidal, fungi-
cidal, sporicidal, and virucidal properties in vitro. H
2
O
2
damages lipid membranes, DNA, and RNA through its
oxidative action. HPV showed effective decontamination
against MRSA, VRE, Acinetobacter spp., K. pneumonia, and
C. difficile spores [36]. H
2
O
2
may be released in three
different forms: dry vapour, wet vapour, and mist. These
three technologies produce H
2
O
2
particles small enough to
diffuse and reach hidden and difficult to reach surfaces.
Recently, Blazejewski et al. [37] investigated the efficiency
of HPV in improving disinfection in ICUs. They applied
HPV after routine terminal cleaning and collected environ-
mental sampling before and after HPV use. After patient
discharge, 8% of sampled rooms were contaminated with
at least 1 MDRO. Routine terminal cleaning reduced the
environmental bacterial load but authors did not detect a
statistically significant difference in the degree of MDROs
contamination [37]. HPV, instead, significantly reduced the
residual environmental contamination by MDROs. Given
the high costs for implementation of no-touch terminal
cleaning methods in ICUs (i.e., machines and maintenance
costs, additional staff members), further studies are needed
to evaluate their impact for patient-centred outcomes.
2. How Bacteria Survive on Inanimate Surfaces
and after Terminal Cleaning Procedures?
The principal factors associated with the ability of a nosoco-
mial pathogen to survive on inanimate surfaces and equip-
ment are the specific microorganism characteristics (such as
genus, species, specific strain, ability to form biofilm, and
microorganism concentration) and the environmental fac-
tors (such as UV radiation, temperature, humidity, presence
of organic materials, and surface type) [38–40]. Evidence
on the capacity to survive in environmental reservoirs has
been reported for bacteria (C. difficile, VRE, MRSA, P.
aeruginosa, Escherichia coli, Klebsiella spp., andAcinetobacter
spp.), viruses (influenza, parainfluenza, enteric, hepatitis B
viruses), and fungi (Candida albicans,Candida glabrata, Can-
dida parapsilosis, Aspergillus spp., and Zygomycetes) [41–47].
Microorganisms are able to survive on surfaces because of
their production of adhesion molecules and biofilms. These
abilities are favoured when microorganisms grow on mate-
rials with high absorptive capacity [48]. Coagulase-negative
staphylococci are able to survive up to 8–21 days on cotton
used to produce clothing and towels, while P. aeruginosa
survives for only 2–24 hours on the same surface. Even dif-
ferent species from the same genus showed different survival
capacity [42]. As an example, C. parapsilosis showed higher
resistance when compared to C. albicans or C. krusei [49].
Intrinsic microbiologic features also influence the resistance
against disinfectants. For example, mycobacteria have a waxy
cell wall able to prevent disinfectants entry, whereas Gram-
negative bacteria have an outer membrane acting as a barrier
preventing the uptake of disinfectants [50]. Concentration
of Gram-positive and Gram-negative bacteria, fungi, and
viruses may influence their persistence on surfaces; the
greater the microbial load, the longer the survival capacity.
A biofilm is a structured community of microorganisms
encased and attached to surfaces by exopolymeric substances
(EPS). Up to 90% of biofilm are made of EPS, which provides
protection against environmental desiccation. Biofilm plays
an important role in catheter-related infections and of other
indwelling medical devices [51]. Bacteria are able to form
biofilm also on dry inanimate surfaces. It has been speculated
that biofilm formation may be enhanced by a thin film of
water resulting from condensation on surfaces or that the
relative humidity of ICUs is sufficiently high to allow biofilm
formation [52]. Biofilms contain a high bacterial load able to
survive on dry hospital surfaces for a long time, showing also
an increased resistance towards inactivation by disinfectants.
Indeed, bacteria in the biofilm are up to 1000-fold more
resistant to disinfectants than their corresponding planktonic
form [40, 52–55].P. aeruginosa biofilmonflexible endoscopes
surfaces is able to survive 5-minute treatment with peracetic
acid at 2000 parts per million concentration, which is the
working concentration used by some washer-disinfectors
[54].
Vickery et al. [52] investigated the persistence of reser-
voirs of MDROs within biofilm after terminal cleaning in an
ICU. Equipment and furnishings were aseptically removed
from the ICU, scanned by electron microscopy and cultured.
Biofilm was demonstrated on 4 of the five different samples
from the patient zone and healthcare area. Cultures from
samples led to MRSA growth. This finding highlights one
possible explanation of the suboptimal terminal cleaning
efficacy and the persistence of a reservoir of MDROs possibly
involved in direct or indirect (via HCWs’ hands) cross-
transmission [52]. This should be considered in the broader
perspective of emergence of MDROs, stewardship initiatives,
and infection control measures [45, 56–58].
The increased resistance of biofilms to disinfectants is
supposed to be due to the following factors:
(i) gene regulation of microorganisms with increased
lateral gene transfer and mutation rates [59];
(ii) phenotypic adaptation of cells to sublethal disinfec-
tant concentration [60];
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(iii) production of EPS surrounding the bacteria.The EPS
reduces the penetration of biocides into the biofilm,
inactivates some disinfectants by binding to them,
and inactivates some disinfectants by liberation of
enzymes [61];
(iv) biofilm which can be composed by different microor-
ganism species constituting a polymicrobial biofilm
with a higher resistance to disinfectants compared
to monospecies biofilms [61]. The mechanism of this
increased resistance may result from an increased
disinfectant inactivation due to a more complex EPS
or from shielding of sensitive organisms by externally
situated disinfectant tolerant organisms [62].
Among environmental variables, ultraviolet (UV) light, tem-
perature, humidity, and presence of organic material have
been reported to have a major role in influencing microbial
viability. Visible light and UV radiation are generally dele-
terious to microorganisms. Temperatures higher than 50∘C
are able to kill most Candida spp. while low temperatures
(4∘C to 6∘C) increase survival times for many bacteria.
Humidity can have variable effects on the persistence of
microorganisms on surfaces. Yeast showed a better survive
at higher humidity [42]. Organic matter (e.g., blood, serum,
sputum, pus, fecal material) may play both a direct and
an indirect role to enhance environmental resistance of
microorganisms. The direct role is the barrier effect pro-
tecting microorganisms from environmental physical and
chemical agents. The indirect role is the interference of
organicmatter with the antimicrobial activity of disinfectants
through chemical reactions resulting in a complex exhibiting
less germicidal or nongermicidal properties and leaving a
reduced quantity of active disinfectant agents.This frequently
occurs with chlorine and iodine disinfectants [63]. In parallel
with development of new strategies to enhance disinfectant
agents’ efficacy, different research groups are now focusing
on development of novel materials which may potentially
be used to prevent or reduce contamination and biofilm
formation by bacteria, including MDROs. Metal-embedded
surfaces (copper, gallium, and titanium) were effective at
preventing planktonic and biofilm growth of P. aeruginosa,
S. aureus, and E. coli tested strains [64]. In a recently
published observational study, silver-embedded screens used
to separate ICU beds were more effective than traditional
cloth screens at reducing surfaces contamination and cross-
transmission of pathogens [65].
3. Conclusions
Inanimate surfaces and equipment contamination play a
major role in cross-transmission of pathogens in ICUs.
Bacteria, including MDROs, may survive for a long time to
environmental physical and chemical agents and have been
isolated from different surfaces and equipment of the patient
zone and of the healthcare area [8]. Traditional terminal
cleaningmethods showedmajor flaws and no-touchmethods
are under investigation [24, 34]. Clinicians should be aware
of the issue of environmental contamination and consider it
in the broader perspective of infection control measures and
stewardship initiatives [58].
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